{"nctId":"NCT00943306","briefTitle":"Long Term, Follow-on Study of Lomitapide in Patients With Homozygous Familial Hypercholesterolemia","startDateStruct":{"date":"2009-10-29","type":"ACTUAL"},"conditions":["Familial Hypercholesterolemia"],"count":19,"armGroups":[{"label":"lomitapide","type":"EXPERIMENTAL","interventionNames":["Drug: lomitapide"]}],"interventions":[{"name":"lomitapide","otherNames":["AEGR-733","BMS-201038"]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n1. Completed UP1002 or 733-005.\n2. Willing and able to provide consent and comply with the requirements of the study protocol.\n\nExclusion Criteria:\n\n1. Met any of the stopping rules for study discontinuation at the final visit of study UP1002 or 733-005.","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":true},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Percent Change in Low Density Lipoprotein Cholesterol (LDL-C)","description":"Percent Change in Low Density Lipoprotein Cholesterol (LDL-C) from Baseline (Week 0 of Study 733-005/UP1002) to Week 126 (Week 48 in Study AEGR-733-012).","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-45.5","spread":"31.35"}]}]}]},{"type":"SECONDARY","title":"Percent Change in Low Density Lipoprotein Cholesterol (LDL-C)","description":"Percent change in Low Density Lipoprotein Cholesterol (LDL-C) from Baseline (Week 0 of Study 733-005/UP1002) to Week 174 (Week 96 in Study AEGR-733-012).","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-51.0","spread":"16.03"}]}]}]},{"type":"SECONDARY","title":"Percent Change in Low Density Lipoprotein Cholesterol (LDL-C)","description":"Percent change in Low Density Lipoprotein Cholesterol (LDL-C) from Baseline (Week 0 of Study 733-005/UP1002) to Week 222 (Week 144 in Study AEGR-733-012).","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-58.5","spread":"24.25"}]}]}]},{"type":"SECONDARY","title":"Percent Change in Low Density Lipoprotein Cholesterol (LDL-C)","description":"Percent change in Low Density Lipoprotein Cholesterol (LDL-C) from Baseline (Week 0 of Study 733-005/UP1002) to Week 246 (Week 168 in Study AEGR-733-012).","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-60.1","spread":"18.51"}]}]}]},{"type":"SECONDARY","title":"Percent Change in Low Density Lipoprotein Cholesterol (LDL-C)","description":"Percent change in Low Density Lipoprotein Cholesterol (LDL-C) from Baseline (Week 0 of Study 733-005/UP1002) to Week 270 (Week 192 in Study AEGR-733-012).","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-74.0","spread":"19.10"}]}]}]},{"type":"SECONDARY","title":"Percent Change in Low Density Lipoprotein Cholesterol (LDL-C)","description":"Percent change in Low Density Lipoprotein Cholesterol (LDL-C) from Baseline (Week 0 of Study 733-005/UP1002) to Week 294 (Week 216 in Study AEGR-733-012).","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-51.1","spread":"10.11"}]}]}]},{"type":"SECONDARY","title":"Percent Change in Total Cholesterol","description":"Percent change in Total Cholesterol from Baseline (Week 0 of Study 733-005/UP1002) to Week 126 (Week 48 in Study AEGR-733-012).","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-43.2","spread":"25.35"}]}]}]},{"type":"SECONDARY","title":"Percent Change in Total Cholesterol","description":"Percent change in Total Cholesterol from Baseline (Week 0 of Study 733-005/UP1002) to Week 174 (Week 96 in Study AEGR-733-012).","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-46.9","spread":"15.21"}]}]}]},{"type":"SECONDARY","title":"Percent Change in Total Cholesterol","description":"Percent change in Total Cholesterol from Baseline (Week 0 of Study 733-005/UP1002) to Week 222 (Week 144 in Study AEGR-733-012).","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-51.0","spread":"21.34"}]}]}]},{"type":"SECONDARY","title":"Percent Change in Total Cholesterol","description":"Percent change in Total Cholesterol from Baseline (Week 0 of Study 733-005/UP1002) to Week 246 (Week 168 in Study AEGR-733-012).","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-54.1","spread":"16.88"}]}]}]},{"type":"SECONDARY","title":"Percent Change in Total Cholesterol","description":"Percent change in Total Cholesterol from Baseline (Week 0 of Study 733-005/UP1002) to Week 270 (Week 192 in Study AEGR-733-012).","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-65.2","spread":"15.97"}]}]}]},{"type":"SECONDARY","title":"Percent Change in Total Cholesterol","description":"Percent change in Total Cholesterol from Baseline (Week 0 of Study 733-005/UP1002) to Week 294 (Week 216 in Study AEGR-733-012).","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-43.9","spread":"5.01"}]}]}]},{"type":"SECONDARY","title":"Percent Change in Apolipoprotein B (Apo B)","description":"Percent change in Apolipoprotein B (Apo B) from Baseline (Week 0 of Study 733-005/UP1002) to Week 126 (Week 48 in Study AEGR-733-012).","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-53.6","spread":"23.74"}]}]}]},{"type":"SECONDARY","title":"Percent Change in Apolipoprotein B (Apo B)","description":"Percent change in Apolipoprotein B (Apo B) from Baseline (Week 0 of Study 733-005/UP1002) to Week 174 (Week 96 in Study AEGR-733-012).","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-59.4","spread":"12.60"}]}]}]},{"type":"SECONDARY","title":"Percent Change in Apolipoprotein B (Apo B)","description":"Percent change in Apolipoprotein B (Apo B) from Baseline (Week 0 of Study 733-005/UP1002) to Week 222 (Week 144 in Study AEGR-733-012).","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-65.1","spread":"20.72"}]}]}]},{"type":"SECONDARY","title":"Percent Change in Apolipoprotein B (Apo B)","description":"Percent change in Apolipoprotein B (Apo B) from Baseline (Week 0 of Study 733-005/UP1002) to Week 246 (Week 168 in Study AEGR-733-012).","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-65.9","spread":"15.76"}]}]}]},{"type":"SECONDARY","title":"Percent Change in Apolipoprotein B (Apo B)","description":"Percent change in Apolipoprotein B (Apo B) from Baseline (Week 0 of Study 733-005/UP1002) to Week 270 (Week 192 in Study AEGR-733-012).","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-76.7","spread":"16.09"}]}]}]},{"type":"SECONDARY","title":"Percent Change in Apolipoprotein B (Apo B)","description":"Percent change in Apolipoprotein B (Apo B) from Baseline (Week 0 of Study 733-005/UP1002) to Week 294 (Week 216 in Study AEGR-733-012).","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-60.9","spread":"12.17"}]}]}]},{"type":"SECONDARY","title":"Percent Change in Triglycerides","description":"Percent change in Triglycerides from Baseline (Week 0 of Study 733-005/UP1002) to Week 126 (Week 48 in Study AEGR-733-012).","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-37.5","spread":"42.52"}]}]}]},{"type":"SECONDARY","title":"Percent Change in Triglycerides","description":"Percent change in Triglycerides from Baseline (Week 0 of Study 733-005/UP1002) to Week 174 (Week 96 in Study AEGR-733-012).","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-31.7","spread":"37.09"}]}]}]},{"type":"SECONDARY","title":"Percent Change in Triglycerides","description":"Percent change in Triglycerides from Baseline (Week 0 of Study 733-005/UP1002) to Week 222 (Week 144 in Study AEGR-733-012).","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-27.6","spread":"48.88"}]}]}]},{"type":"SECONDARY","title":"Percent Change in Triglycerides","description":"Percent change in Triglycerides from Baseline (Week 0 of Study 733-005/UP1002) to Week 246 (Week 168 in Study AEGR-733-012).","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-41.9","spread":"33.16"}]}]}]},{"type":"SECONDARY","title":"Percent Change in Triglycerides","description":"Percent change in Triglycerides from Baseline (Week 0 of Study 733-005/UP1002) to Week 270 (Week 192 in Study AEGR-733-012).","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-48.5","spread":"34.24"}]}]}]},{"type":"SECONDARY","title":"Percent Change in Triglycerides","description":"Percent change in Triglycerides from Baseline (Week 0 of Study 733-005/UP1002) to Week 294 (Week 216 in Study AEGR-733-012).","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"29.2","spread":"58.74"}]}]}]},{"type":"SECONDARY","title":"Percent Change in Non High Density Lipoprotein Cholesterol (Non-HDL-C)","description":"Percent change in Non High Density Lipoprotein Cholesterol (Non-HDL-C) from Baseline (Week 0 of Study 733-005/UP1002) to Week 126 (Week 48 in Study AEGR-733-012).","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-47.1","spread":"27.83"}]}]}]},{"type":"SECONDARY","title":"Percent Change in Non High Density Lipoprotein Cholesterol (Non-HDL-C)","description":"Percent change in Non High Density Lipoprotein Cholesterol (Non-HDL-C) from Baseline (Week 0 of Study 733-005/UP1002) to Week 174 (Week 96 in Study AEGR-733-012).","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-53.5","spread":"16.42"}]}]}]},{"type":"SECONDARY","title":"Percent Change in Non High Density Lipoprotein Cholesterol (Non-HDL-C)","description":"Percent change in Non High Density Lipoprotein Cholesterol (Non-HDL-C) from Baseline (Week 0 of Study 733-005/UP1002) to Week 222 (Week 144 in Study AEGR-733-012).","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-57.0","spread":"24.07"}]}]}]},{"type":"SECONDARY","title":"Percent Change in Non High Density Lipoprotein Cholesterol (Non-HDL-C)","description":"Percent change in Non High Density Lipoprotein Cholesterol (Non-HDL-C) from Baseline (Week 0 of Study 733-005/UP1002) to Week 246 (Week 168 in Study AEGR-733-012).","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-58.8","spread":"17.73"}]}]}]},{"type":"SECONDARY","title":"Percent Change in Non High Density Lipoprotein Cholesterol (Non-HDL-C)","description":"Percent change in Non High Density Lipoprotein Cholesterol (Non-HDL-C) from Baseline (Week 0 of Study 733-005/UP1002) to Week 270 (Week 192 in Study AEGR-733-012).","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-71.5","spread":"17.65"}]}]}]},{"type":"SECONDARY","title":"Percent Change in Non High Density Lipoprotein Cholesterol (Non-HDL-C)","description":"Percent change in Non High Density Lipoprotein Cholesterol (Non-HDL-C) from Baseline (Week 0 of Study 733-005/UP1002) to Week 294 (Week 216 in Study AEGR-733-012).","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-46.6","spread":"5.19"}]}]}]},{"type":"SECONDARY","title":"Percent Change in Very Low Density Lipoprotein Cholesterol (VLDL-C)","description":"Percent change in Very Low Density Lipoprotein Cholesterol (VLDL-C) from Baseline (Week 0 of Study 733-005/UP1002) to Week 126 (Week 48 in Study AEGR-733-012).","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-36.8","spread":"43.90"}]}]}]},{"type":"SECONDARY","title":"Percent Change in Very Low Density Lipoprotein Cholesterol (VLDL-C)","description":"Percent change in Very Low Density Lipoprotein Cholesterol (VLDL-C) from Baseline (Week 0 of Study 733-005/UP1002) to Week 174 (Week 96 in Study AEGR-733-012).","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-31.5","spread":"36.32"}]}]}]},{"type":"SECONDARY","title":"Percent Change in Very Low Density Lipoprotein Cholesterol (VLDL-C)","description":"Percent change in Very Low Density Lipoprotein Cholesterol (VLDL-C) from Baseline (Week 0 of Study 733-005/UP1002) to Week 222 (Week 144 in Study AEGR-733-012).","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-26.3","spread":"49.94"}]}]}]},{"type":"SECONDARY","title":"Percent Change in Very Low Density Lipoprotein Cholesterol (VLDL-C)","description":"Percent change in Very Low Density Lipoprotein Cholesterol (VLDL-C) from Baseline (Week 0 of Study 733-005/UP1002) to Week 246 (Week 168 in Study AEGR-733-012).","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-41.4","spread":"34.20"}]}]}]},{"type":"SECONDARY","title":"Percent Change in Very Low Density Lipoprotein Cholesterol (VLDL-C)","description":"Percent change in Very Low Density Lipoprotein Cholesterol (VLDL-C) from Baseline (Week 0 of Study 733-005/UP1002) to Week 270 (Week 192 in Study AEGR-733-012).","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-48.7","spread":"33.41"}]}]}]},{"type":"SECONDARY","title":"Percent Change in Very Low Density Lipoprotein Cholesterol (VLDL-C)","description":"Percent change in Very Low Density Lipoprotein Cholesterol (VLDL-C) from Baseline (Week 0 of Study 733-005/UP1002) to Week 294 (Week 216 in Study AEGR-733-012).","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"30.6","spread":"59.94"}]}]}]},{"type":"SECONDARY","title":"Percent Change in Lp(a)","description":"Percent change in Lp(a) from Baseline (Week 0 of Study 733-005/UP1002) to Week 126 (Week 48 in Study AEGR-733-012).","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"5.5","spread":"43.62"}]}]}]},{"type":"SECONDARY","title":"Percent Change in Lp(a)","description":"Percent change in Lp(a) from Baseline (Week 0 of Study 733-005/UP1002) to Week 174 (Week 96 in Study AEGR-733-012).","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"10.2","spread":"60.64"}]}]}]},{"type":"SECONDARY","title":"Percent Change in Lp(a)","description":"Percent change in Lp(a) from Baseline (Week 0 of Study 733-005/UP1002) to Week 222 (Week 144 in Study AEGR-733-012).","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-12.8","spread":"49.00"}]}]}]},{"type":"SECONDARY","title":"Percent Change in Lp(a)","description":"Percent change in Lp(a) from Baseline (Week 0 of Study 733-005/UP1002) to Week 246 (Week 168 in Study AEGR-733-012).","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"3.4","spread":"54.22"}]}]}]},{"type":"SECONDARY","title":"Percent Change in Lp(a)","description":"Percent change in Lp(a) from Baseline (Week 0 of Study 733-005/UP1002) to Week 270 (Week 192 in Study AEGR-733-012).","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-6.6","spread":"48.99"}]}]}]},{"type":"SECONDARY","title":"Percent Change in Lp(a)","description":"Percent change in Lp(a) from Baseline (Week 0 of Study 733-005/UP1002) to Week 294 (Week 216 in Study AEGR-733-012).","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-10.4","spread":"35.64"}]}]}]},{"type":"SECONDARY","title":"Percent Change in High Density Lipoprotein Cholesterol (HDL-C)","description":"Percent change in High Density Lipoprotein Cholesterol (HDL-C) from Baseline (Week 0 of Study 733-005/UP1002) to Week 126 (Week 48 in Study AEGR-733-012).","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-8.3","spread":"19.28"}]}]}]},{"type":"SECONDARY","title":"Percent Change in High Density Lipoprotein Cholesterol (HDL-C)","description":"Percent change in High Density Lipoprotein Cholesterol (HDL-C) from Baseline (Week 0 of Study 733-005/UP1002) to Week 174 (Week 96 in Study AEGR-733-012).","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"3.8","spread":"26.51"}]}]}]},{"type":"SECONDARY","title":"Percent Change in High Density Lipoprotein Cholesterol (HDL-C)","description":"Percent change in High Density Lipoprotein Cholesterol (HDL-C) from Baseline (Week 0 of Study 733-005/UP1002) to Week 222 (Week 144 in Study AEGR-733-012).","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-2.7","spread":"21.22"}]}]}]},{"type":"SECONDARY","title":"Percent Change in High Density Lipoprotein Cholesterol (HDL-C)","description":"Percent change in High Density Lipoprotein Cholesterol (HDL-C) from Baseline (Week 0 of Study 733-005/UP1002) to Week 246 (Week 168 in Study AEGR-733-012).","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-12.5","spread":"19.17"}]}]}]},{"type":"SECONDARY","title":"Percent Change in High Density Lipoprotein Cholesterol (HDL-C)","description":"Percent change in High Density Lipoprotein Cholesterol (HDL-C) from Baseline (Week 0 of Study 733-005/UP1002) to Week 270 (Week 192 in Study AEGR-733-012).","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-10.3","spread":"27.68"}]}]}]},{"type":"SECONDARY","title":"Percent Change in High Density Lipoprotein Cholesterol (HDL-C)","description":"Percent change in High Density Lipoprotein Cholesterol (HDL-C) from Baseline (Week 0 of Study 733-005/UP1002) to Week 294 (Week 216 in Study AEGR-733-012).","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-23.5","spread":"2.27"}]}]}]},{"type":"SECONDARY","title":"Percent Change in Apolipoprotein AI (Apo AI)","description":"Percent change in Apolipoprotein AI (Apo AI) from Baseline (Week 0 of Study 733-005/UP1002) to Week 126 (Week 48 in Study AEGR-733-012).","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-14.0","spread":"17.71"}]}]}]},{"type":"SECONDARY","title":"Percent Change in Apolipoprotein AI (Apo AI)","description":"Percent change in Apolipoprotein AI (Apo AI) from Baseline (Week 0 of Study 733-005/UP1002) to Week 174 (Week 96 in Study AEGR-733-012).","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-8.2","spread":"20.12"}]}]}]},{"type":"SECONDARY","title":"Percent Change in Apolipoprotein AI (Apo AI)","description":"Percent change in Apolipoprotein AI (Apo AI) from Baseline (Week 0 of Study 733-005/UP1002) to Week 222 (Week 144 in Study AEGR-733-012).","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-2.7","spread":"33.30"}]}]}]},{"type":"SECONDARY","title":"Percent Change in Apolipoprotein AI (Apo AI)","description":"Percent change in Apolipoprotein AI (Apo AI) from Baseline (Week 0 of Study 733-005/UP1002) to Week 246 (Week 168 in Study AEGR-733-012).","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-16.8","spread":"26.62"}]}]}]},{"type":"SECONDARY","title":"Percent Change in Apolipoprotein AI (Apo AI)","description":"Percent change in Apolipoprotein AI (Apo AI) from Baseline (Week 0 of Study 733-005/UP1002) to Week 270 (Week 192 in Study AEGR-733-012).","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-17.8","spread":"20.12"}]}]}]},{"type":"SECONDARY","title":"Percent Change in Apolipoprotein AI (Apo AI)","description":"Percent change in Apolipoprotein AI (Apo AI) from Baseline (Week 0 of Study 733-005/UP1002) to Week 294 (Week 216 in Study AEGR-733-012).","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-30.5","spread":"22.2"}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":7,"n":19},"commonTop":["Diarrhoea","Nausea","Headache","Vomiting","Influenza"]}}}